SLC26A4/PDS mutations cause Pendred Syndrome and non-syndromic deafness. but some aspects of function and regulation of the SLC26A4 polypeptide gene product, pendrin, remain controversial or incompletely understood. We have therefore extended the functional analysis of wildtype and mutant pendrin in Xenopus oocytes, with studies of isotopic flux, electrophysiology, and protein localization. Pendrin mediated electroneutral, pHinsensitive, DIDS-insensitive anion exchange, with extracellular K (1/2) (in mM) of 1.9 (Cl -), 1.8 (I -), and 0.9 (Br -). The unusual phenotype of Pendred Syndrome mutation E303Q (loss-of-function with normal surface expression) prompted systematic mutagenesis at position 303. Only mutant E303K exhibited loss-offunction unrescued by forced overexpression. Mutant E303C was insensitive to charge modification by methanethiosulfonates. The corresponding mutants SLC26A2 E336Q, SLC26A3 E293Q, and SLC26A6 E298Q exhibited similar loss-of-function phenotypes, with wildtype surface expression also documented for SLC26A2 E336Q. The strong inhibition of wildtype SLC26A2, SLC26A3, and SLC26A6 by phorbol ester contrasts with its modest inhibition of pendrin. Phorbol ester inhibition of SLC26A2, SLC26A3, and SLC26A6 was blocked by coexpressed kinase-dead PKCδ but was without effect on pendrin. Mutation of SLC26A2 serine residues conserved in PKCδ -sensitive SLC26 proteins but absent from pendrin failed to reduce PKCδ sensitivity of SLC26A2 (190).
Introduction
Pendrin is the polypeptide product of the SLC26A4/ PDS gene. Pendrin mediates anion exchange, with physiological specificity encompassing chloride, bicarbonate, iodide, and formate. Mutations in the SLC26A4 gene cause nonsyndromic deafness with enlargement of the vestibular aqueduct (EVA; DFNB4) as well as Pendred Syndrome, in which deafness is accompanied by defective thyroid iodide organification 436 evident as an elevated perchlorate discharge test, and incompletely penetrant, often euthyroid goiter [1, 2] . More than 200 SLC26A4 mutations have been catalogued in association with one of these two clinical entities [3, 4] . Among the pendrin missense mutant polypeptides that have been investigated, most are retained inside the cell, likely due to misfolding.
In the cochlea, pendrin is expressed in the epithelial cells of the spiral prominence, root cells, and spindle cells of the stria vascularis. In the vestibular apparatus, pendrin is expressed in nonsensory epithelial cells surrounding sensory hair-cell patches in the saccule, utricle, and ampulla, and in a subset of cells of the endolymphatic sac terminating the vestibular aqueduct [5] . Lack of pendrinmediated Cl -/HCO 3 - exchange in the inner ear acidifies endolymph, thus promoting loss of the endocochlear potential and elevating endolymph [Ca 2+ ] [6, 7] , and likely contributes to enlargement of the cochlear lumen [8] and vestibular aqueduct through reduced volume absorption. Development of normal hearing in the mouse requires pendrin expression between e16.5 and p2 of embryonic and neonatal developent [5] .
Pendrin is also expressed in the apical membrane of the thyrocyte, where it likely mediates Cl -/I -exchange across the thyrocyte apical membrane, contributing to iodide uptake and organification in the lumen of the thyroid follicle [9] . However, loss of pendrin function is often unaccompanied by any thyroid phenotype in both humans and mice, and the importance of pendrin to thyroid follicular iodide secretion remains mysterious, while additional apical thyrocyte iodide transporters remain Pendrin expressed in the apical membrane of non-A intercalated cells of the renal cortical collecting duct [10] mediates Cl -/HCO 3 - exchange. This major transcellular pathway for Cl -reabsorption and HCO 3 - secretion is coupled with the Na + uptake pathway mediated by Slc4a8 [11] , and is regulated by aldosterone, acid and alkaline pH [12] , uroguanylin [13] , and the alkaline pH-sensitive insulin receptor-related receptor [14] .
Pendrin-mediated Cl -/HCO 3 - exchange in the mouse kidney cortical collecting duct (CCD) contributes to mineralocorticoid and high-salt-induced hypertension [15] and regulates ENaC activity [16] , while pendrin-mediated Cl -/I -exchange mediates an important component of renal iodide reabsorption [17] . Although human pendrin deficiency generally lacks any clinical renal phenotype, two cases of acute metabolic alkalosis in the setting of acute precipitating illnesses have been reported in Pendred patients [18] . Pendrin has also been proposed to mediate Cl -/HCO 3 -exchange and SCN -/Cl -exchange in interleukin-stimulated airway epithelial cells [19] , functions postulated to contribute to asthma pathology or adaptation [20] . Pendrin has also been detected in prolactin-stimulated mammary epithelial cells [21, 22] and regulates iodide secretion in submandibular duct of the mouse salivary gland [23] .
Aspects of anion selectivity and acute regulation of pendrin remain controversial or little studied. The physiological consequences of disease-associated mutations unassociated with trafficking abnormalities are similarly understudied. In this paper we address the anion selectivity and physiological regulation of pendrin as expressed in Xenopus oocytes, and explore with directed mutagenesis the role of pendrin residue E303, site of the deafness-associated loss-of-function mutation E303Q associated with normal intracellular trafficking [4] . In addition we re-evaluate the mechanism by which protein kinase C regulates SLC26 anion exchangers, and test a hypothesis addressing the distinct PKC response of pendrin compared to other disease-associated SLC26 anion exchangers. -free. Addition of the weak acid sodium butyrate (40 mM) to the flux media was in equimolar substitution for sodium cyclamate. Bath addition of NH 4 Cl (20 mM) was in equimolar substitution for NaCl.
Materials and Methods

Materials
Mutagenesis of cDNA expression plasmids
Oocyte expression plasmids encoding human pendrin/ SLC26A4 and its mutant E303Q [4] , human SLC26A2/DTDST (hSCL26A2) [24] , hSLC26A3/DRA [25] , hSLC26A6 and mSlc26a6 [26] were previously described. The multiple pendrin E303 mutants, hSLC26A3 mutant E293Q, hSLC26A6 mutant E298Q, hSLC26A2 mutant E336Q and double mutant S245V/ S249A were each generated by four-primer polymerase chain reaction (PCR) mutagenesis as described [27] (oligonucleotide sequences available upon request). PCR-synthesized products and ligation junctions were sequenced in the final plasmids in entirety to ensure absence of PCR-generated mutations. Mouse protein kinase C-δ (PKCδ) [28] kinase-dead variant K376A [29] in pcDL-Srα296 [30] was the gift of A. Toker (Beth Israel Deaconess Med. Ctr.) The kinase-dead PKCδ open reading frame was subcloned into pXT7.
Expression of cRNAs in Xenopus oocytes
Capped cRNA was transcribed from linearized cDNA templates with the T7 or SP6 Megascript Kit (Ambion, Austin, TX) and purified with the RNeasy mini-kit (Qiagen). cRNA concentration (A 260 ) was measured by Nanodrop spectrometer (ThermoFisher), and integrity was confirmed by formaldehyde agarose gel electrophoresis. Mature female Xenopus (Dept. of Systems Biology, Harvard Medical School; or NASCO, Madison, WI) were maintained and subjected to partial ovariectomy under hypothermic tricaine anesthesia following protocols approved by the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center. Stage V-VI oocytes were prepared by overnight incubation of ovarian fragments in MBS with 1.5 mg/ml collagenase B (Roche, Indianapolis, IN), followed by a 20 min rinse in Ca 2+ -free MBS with subsequent manual selection and defolliculation as needed. Oocytes were injected on the same day with cRNA (0.5-50 ng) or with water in a volume of 50 nl. Injected and uninjected oocytes were then maintained before use for 2-6 days at 17.5°C in MBS containing gentamicin. -free baths of 103.6 mM NaCl. To vary pH i at constant pH o , oocytes were pre-exposed to 40 mM sodium butyrate (substituting for sodium cyclamate) for 30 min prior to initiation of an efflux experiment to produce intracellular acidification to pH i 6.8 [32] . Upon removal of bath butyrate (with substitution by sodium cyclamate) during the course of the efflux experiment, pH i rapidly alkalinized back towards initial pH i while pH o remained constant. Variation of pH o was achieved at near-constant pH i [33] . Some oocyte groups were exposed to 20 mM NH 4 Cl during the course of efflux experiments, acidifying pH i to 6.9 [34] . Drugs were added to the bath prior to or together with isotope as indicated.
Isotopic influx experiments
Efflux data were plotted as the natural logarithm (ln) of the quantity (% cpm remaining in the oocyte) vs. 
Two-electrode voltage clamp measurements
Microelectrodes from borosilicate glass made with a Sutter P-87 puller were filled with 3 M KCl and had resistances of 2-3 MΩ. Oocytes previously injected with water or with 10 ng of the indicated cRNA were placed in a 1 ml chamber (model RC-11, Warner Instruments, Hamden CT) on the stage of a dissecting microscope and impaled with microelectrodes under direct view. Steady-state currents achieved within 2-5 min following bath change or drug addition were measured with a Geneclamp 500 amplifier (Axon Instruments, Burlingame, CA) interfaced to a Dell computer with a Digidata 1322A digitizer (Axon). Standard recording bath solution was ND-96 (see above). In anion substitution experiments, NaCl was replaced with sodium cyclamate.
Data acquisition and analysis utilized pCLAMP 8.0 software (Axon). The voltage pulse protocol generated with the Clampex subroutine consisted of 20 mV steps between -100 mV and +40 mV, with durations of 738 msec separated by 30 msec at the holding potential of -30 mV. Bath resistance was minimized by the use of agar bridges filled with 3 M KCl, and a virtual ground circuit clamped bath potential to zero during voltage clamp experiments.
Confocal immunofluorescence microscopy
Two or three days after injection with H 2 0 or with cRNA encoding hSLC26A2, groups of 10-12 oocytes were similarly fixed with 3% PFA and washed with PBS-azide. Oocytes were then placed in PBS containing 1% SDS to permeabilize the surface membranes and unmask epitope. Fixed, permeabilized oocytes were blocked in PBS with 1% bovine serum albumin (PBS-BSA) containing 0.05% saponin for 1 hr at 4°C, then washed three times with PBS-BSA. Oocytes were incubated overnight at 4°C with mouse monoclonal anti-hSLC26A2 antibody IgG2 [24] at 1:400 dilution in PBS-BSA, then washed 3 times in cold PBS-BSA. Antibody-labeled oocytes were then incubated 2 hr at 4°C with Cy3-conjugated secondary goat anti-mouse Ig (Jackson Immunochemicals, diluted 1:500), again thoroughly washed in PBS-BSA, and stored at 4°C until imaging.
Cy3-labeled oocytes were aligned in uniform orientation along a plexiglass groove (gift of P. Grigg, Univ. Mass. Med. Ctr) and sequentially imaged through the 10x objective of a Zeiss LSM510 laser scanning confocal microscope using the 543 nm laser line at 512 x 512 resolution at uniform settings of 80% laser intensity, pinhole 54 (1.0 Airy units), detector gain 650, amplifier gain 1, zero amplifier offset.
Polypeptide abundance at or near each oocyte surface was estimated by quantitation of specific fluorescence intensity (FI) at the circumference of one quadrant of an equatorial focal plane (Image J v. 1.38, National Institutes of Health). Mean background-corrected FI for quadrants of oocytes previously injected with water was subtracted from the backgroundcorrected FI for quadrants of individual cRNA-injected oocytes to yield intensity values for surface-associated specific FI for each oocyte.
Statistics
Data are reported as mean ± SE. Comparisons of two flux data sets was by Student's paired or unpaired two-tailed T tests (Microsoft Excel); multiple flux data were compared by one-way ANOVA with Bonferroni test for post-hoc analysis (SigmaPlot 8.0). Two-electrode voltage clamp currents of control and pendrin-expressing oocytes were compared by unpaired Student's t-test. Currents of pendrin-expressing oocytes in sequential chloride and cyclamate baths were compared by paired Student's t-test. Image intensity data for multiple samples were compared by ANOVA with Bonferroni post-hoc analysis. P < 0.05 was interpreted as significant.
Results
Pendrin-mediated chloride/formate exchange is bidirectional
Recombinant pendrin has been shown to transport formate, chloride, iodide, and/or HCO 3 - in Xenopus oocytes [23, 35] , HEK-293 cells [36] [37] [38] , HeLa cells [39] , and polarized epithelial cells [9] . . Both transport modes were acutely insensitive to 500 µM DIDS. These results agree with the report of Scott et al [35] exchange in the presence and absence (pH 7.4) of 40 mM butyrate (n=9). 
exchange in oocytes was insensitive to pH o changes between 6.0 and 8.5 (Fig. 3A,B) . Moreover, variation in intracellular pH (pH i ) over 0.5 pH units by bath removal of pre-equilibrated 40 mM butyrate similarly failed to alter the rate of 36 Cl
exchange (Fig.  3C,D) . Exposure of pendrin-expressing oocytes to 20 mM NH 4 Cl, which acidifies oocyte pH i to values of ~6.9 [34] , similarly failed to alter the rate of [40] . Both regulations were proposed to reflect allosteric effects of pH rather than changes in substrate anion gradient. [23] and suggested by halide fluorimetry [41] . The data taken together document electroneutrality of pendrinmediated monovalent anion exchange.
Pendrin-mediated Cl
Pendrin inhibitors are few and of low potency
Mouse pendrin and Slc4a8 function as a NaCl cotransporter (NCC)-independent, thiazide-sensitive NaCl reabsorption system of the CCD [11] , suggesting pendrin as a target for novel diuretic or cardiotonic drugs. However, hydrochlorothiazide does not inhibit pendrin at concentrations consistent with this NCC-independent effect [11] . Indeed, strong inhibitors of pendrin have not been identified. Although pendrin is commonly described as DIDS-insensitive, pendrin-mediated Cl -/OH -exchange activity was recently reported as sensitive to 500 µM DIDS [40] , echoing an earlier report of DIDS-sensitivity [37] [4] . E303 of pendrin is modeled at the N-terminal cytoplasmic end of putative transmembrane span 7, based on topographical fusion protein studies of bacterial SulP bicarbonate transporter BicA and plant sulfate transporter SHST1 [43] , although earlier models based solely on hydropathy profiling predicted a more exofacial location. To explore the range of amino acid side chains tolerated at pendrin residue 303, we substituted residues of distinct charge and size. As shown in Fig. 5A for oocytes injected with 1 ng cRNA, all tested substitutions yielded mutants with activity lower than that of wildtype pendrin. However, only substitutions K and S were as severely affected as disease mutant E303Q. Since mutant overexpression allows functional expression of some mutants, we tested the effects of injection of 10 ng mutant cRNA (Fig. 5B) . In this condition, E303 substitutions with D, C, A, S, and N exhibited activity near or exceeding that exhibited by oocytes expressing 1 ng wildtype pendrin. However, E303Q remained hypofunctional, and E303K completely nonfunctional. As the charge reversal mutation E303K produced the most complete loss-of-function, we tested the effect of chemical charge modification at E303C. Oocytes expressing 10 ng cRNA encoding pendrin E303C were treated with extracellular MTSES (to derivatize the Cys sulfhydryl group at position 303 with a negative charge), MTSET (to confer a positive charge), or MTSEA (to confer a pH-sensitive positive charge). None of the MTS reagents reduced 36 Cl -influx by oocytes expressing pendrin E303C. Thus, E303 of pendrin was inaccessible to all MTS reagents, consistent with a location within the bilayer or forming part of a cytoplasmic surface vestibule [43] . Alternatively, introduction of positive charge at E303 does not suffice to replicate the functional deficit of mutant E303K, and side chain steric factors may also be important.
E-to-Q mutations in other SLC26 polypeptides at positions analogous to pendrin E303
The conservation of pendrin E303 among nearly all SLC26 polypeptides [4] prompted a test of the hypothesis that the functional characteristics of pendrin mutant E303Q are also conserved in the corresponding mutants of other SLC26 anion exchangers. Human SLC26A2 mediates sulfate uptake into Xenopus oocytes [24] , but SLC26A2 mutant E336Q exhibited nearly complete loss-of-function whether influx was measured in 1 mM or 20 mM sulfate, or after injection of 40-fold excess mutant cRNA (Fig.  6A) . Despite its loss-of-transport function, SLC26A2 E336Q was expressed at the oocyte surface at wild-type abundance (Fig. 6B) , resembling pendrin E303Q in both respects. Human SLC26A3-mediated 36 Cl -uptake was completely abolished in SLC26A3 mutant E293Q (Fig.  6C) . The mutation also abolished SLC26A3-mediated 36 Cl
exchange (Fig. 6D) . The exchange activity of human SLC26A6 [26, 44] was nearly abolished by the homologous SLC26A6 mutation E298Q (Fig. 7A,B) . SLC26A6-mediated uptakes of 14 C-oxalate (Fig. 7C) and of 36 Cl - (Fig. 7D) were similarly impaired by the E298Q mutation. Thus, E-to-Q missense substitutions in SLC26A2, -A3, and -A6 in positions homologous to E303 of pendrin produce similar loss-of-function phenotypes. 
Pendrin differs from SLC26A2, SLC26A3, and SLC26A6 in its lack of inhibition by protein kinase Cδ
Mouse Slc26a6/CFEX was shown by Hassan et al. to be inhibited by the protein kinase C (PKC) agonist phorbol 12-myristate 13-acetate (PMA), whereas pendrin was insensitive to PMA. This PMA inhibition of Slc26a6 was not reversed by inhibitors of classical PKC isoforms, but was partially reversed by rottlerin, a drug used as an inhibitor of protein kinase Cδ, (PKCδ) [45] . However, rottlerin does not inhibit purified recombinant PKCδ [46] but may indirectly inhibit a range of kinases by uncoupling mitochondrial respiration to lower cellular [ATP] [47, 48] . This and other pharmacological actions, such as activation of the BKCa channel [49] , left unclear the mechanism by which rottlerin antagonized inhibition of Slc26a6 by PMA [50] .
We re-examined the role of PKCδ as a selective regulator of SLC26 transporters by assessing the effect of PMA on SLC26 transporters coexpressed without or with the kinase-dead K376A variant of mouse PKCδ (PKCδ-KD; [29] ). As shown in Fig. 8A and summarized in Fig. 8C , PMA exposure inhibited pendrin-mediated exchange by at least 80%, but coexpression with PKCδ-KD largely prevented the inhibitory effect of PMA treatment (Fig. 8B, 8C ). PMA exposure also inhibited mouse Slc26a6-mediated exchange by 70%. In each case, co-expression of PKCδ-KD largely abrogated the inhibition produced by 30 min exposure to PMA. Thus, PMA dramatically reduces anion exchange activity of SLC26A6, SLC26A3, and SLC26A2, and this effect is indeed largely through activation of PKCδ as originally proposed for mSlc26a6-mediated oxalate influx [45] . In contrast, the modest inhibition of pendrin by PMA was not mediated through PKCδ.
Pendrin insensitivity to PKCδ is not explained by the absence of two candidate Ser residues conserved in PMA-responsive SLC26 anion exchangers Since activated PKCδ strongly inhibits SLC26A6, A3, and A2, but does not inhibit pendrin, we searched for Ser and Thr residues conserved in SLC26A6, -A3, and -A2, but not in SLC26A4. One such Ser residue (Fig. 9A,  asterisk) is present in all the PKCδ-sensitive transporters in the second intracellular loop between putative transmembrane spans 4 and 5 (per topography of [43] ), but not in pendrin. A Thr residue three positions away in SLC26A6 and another Ser residue four residues away in SLC26A2 also align with non-phosphorylatable residues in pendrin (Fig. 9A) . We tested these residues as candidate phosphorylation targets for PKCδ-mediated inhibition of SLC26A2. Residues S249 and S245 of SLC26A2 were mutated to the corresponding pendrin residues, and the resulting SLC26A2 double mutant was examined for loss of PMA-sensitivity of sulfate uptake, and acquisition of the PMA-resistant phenotype of pendrin. As shown in Fig. 9B , SLC26A2 double mutant S245V/S249A was inhibited by PMA to the same degree as was wildtype SLC26A2. Although the double mutant exhibited reduced functional expression levels, the preserved inhibitory effect of PMA was evident in oocytes injected with either 0.5 or 5 ng cRNA (associated with function equivalent to that of 0.5 ng wildtype SLC26A2). Thus, inhibition by PMA of SLC26A2 does not require phosphorylation of the two studied serine residues of the second intracellular loop of the transmembrane domain that are not present in the corresponding positions of pendrin. We hypothesize that the corresponding phosphorylatable residues in SLC26A3 (S206) and SLC26A6 (S190) are also not required for inhibition by PMA-activated PKCδ.
Discussion
Anion selectivity and affinity Pendrin and many SLC26 paralogs transport multiple anions in varied physiological and in vitro contexts. It is then of interest to compare pendrin's rank orders of anion transport rate and cis-competition, and to compare these rank orders with those of other SLC26 and SLC4 anion exchangers and conductances. The interaction between a mobile anion substrate and its transporter binding site (both modeled as hard spheres) was represented by Eisenman (with elaboration by Wright, Diamond, and others) as a balance between the enthalpic energy of substrate anion dehydration and the electrostatic interaction between dehydrated anion and its transporter binding site. This balance was described by the concept of electrostatic field strength of the binding site [51] . For high field-strength sites (Eisenman sequence 5), the enthalpic energy of anion dehydration exceeds that of the ion's electrostatic interaction with the idealized binding site, whereas for low field-strength sites (Eisenman sequence 1), the electrostatic interaction of ion with binding site exceeds that of anion dehydration. Although this formulation did not consider entropic costs of ion binding, binding site dynamics within the protein influencing kinetics of anion desolvation and binding, or possible roles of water molecules within or adjacent to the binding site [52, 53] , the resulting predicted anion rank orders 1 through 5 can account for most cases of biological anion transport.
Pendrin expressed in Xenopus oocytes displays an extracellular K 1/2 halide rank order of Br [54, 55] . Thus the V max halide rank order of human pendrin in Xenopus oocytes parallels that of putative rabbit CCD pendrin. However, distinct halide rank orders apply for pendrin V max , K 1/2 , and external cisinhibition, likely reflecting different electric field strengths in the vicinity of pendrin amino acid residues governing ion translocation, anion binding and release, and competitor anion binding. Rank orders of cis-inhibition displayed lower field strength patterns, suggesting involvement of peripheral binding sites.
Mouse Slc26a6-mediated oocyte [57] . Xenopus oocytes expressing human AE1 Δ6-7 (an engineered mutant lacking putative transmembrane spans 6 and 7) exhibited the same halide rank order of anion conductance [58] [60] . Thus, permselectivities associated with recombinant SLC26A9 in oocytes and with native erythrocyte SLC4A1 shared Eisenman sequence 1, suggesting anion binding sites of low field strength rather than the high field strength associated with sites involved in SLC4-and SLC26-mediated anion exchange. However, conductance rank orders differed between the ion channel activities of SLC26A9 and SLC26A7, and permselectivity and conductance rank orders differed for SLC26A9.
Our finding of electroneutral Cl [23] . The slightly elevated bath Cl --independent current observed in pendrin-expressing oocytes might be related to previous reports of pendrin overexpression-associated activation in HEK-293 cells of apparently endogenous cation currents [61] and activation in COS-7 cells of currents of different character [62] . ] imposed by the assay. However, pendrin regulation by both pH i and pH o was interpreted as allosteric, based on mathematical modeling with the assumption of symmetrical intracellular and extracellular binding affinities for each ion [40] . This assumption disregards the different amino acid side chains surrounding internal and external anion binding sites, and contrasts with evidence for SLC4A1/AE1 indicating divergent apparent binding affinities of internal and external anion binding sites [63] . Tests of pH-dependence of anion rank order have not been reported for K 1/2 , k max , or cis-inhibition of pendrinmediated anion exchange. [71] . Modeling of SLC26 transporters on the structure of the E. coli Clc-ec1 Cl -/H + exchanger polypeptide, although unrelated in primary sequence, identified two highly conserved glutamate residues with important roles in tight coupling of anion exchange [72] .
Sensitivity of pendrin activity to pH
Sensitivity of pendrin activity to inhibitors
Pendrin E303Q is unusual as a Pendred Syndrome mutation in its combination of severe loss-of-function with retention of oocyte surface expression [4] . E303 may reside in the middle of putative TM7 [43] , a transmembrane span modeled to include several charged residues. Pendrin E303 is conserved among 9 of 10 SLC26 polypeptides, with minimal divergence to Asp in SLC26A7. The corresponding E-to-Q mutations in SLC26A2, SLC26A3, and SLC26A6 produce similar phenotypes of loss-of-transport function and (in the case of SLC26A2) maintenance of wildtype surface expression. These data support the contention that this Glu residue also contributes in important ways to the anion exchange mechanism of these several SLC26 polypeptides. The lack of effect of MTS reagents on functional mutant pendrin E303C suggests side chain inaccessibility under the high bath Cl -conditions tested. Several E303 mutants were hypofunctional in oocytes, but with the sole exception of E303K, activity of the other mutants was partially or fully rescued by forcing overexpression. This phenotype suggests milder, stochastic folding defects that might be unmasked with longer time or higher temperature.
Pendrin differs from other SLC26 anion exchangers in its insensitivity to inhibition by PKCδ
Hassan et al. demonstrated the powerful inhibition by phorbol ester of mSlc26a6/CFEX but not pendrin expressed in Xenopus oocytes. They further showed that inhibitors of classical PKCs were ineffective in countering the effect of PMA. However, attenuation of the PMA effect by 10 µM rottlerin prompted the proposal that the PMA effect reflected activation of PKCδ, and that PKCδ inhibited mSlc26a6 but not pendrin [45] .
Since the specificity and efficacy of rottlerins's action on PKCδ has been questioned [46, 48] , we investigated the role of PKCδ in PMA regulation of SLC26 anion exchangers by assessing the effects of coexpression of kinase-dead PKCδ. We confirmed PMA inhibition of mSlc26a6, and showed that PMA also inhibited hSLC26A6, hSLC26A3, and hSLC26A2. We further showed that PMA only modestly inhibited pendrinmediated dead PKCδ with SLC26 exchangers led to reduction or abolition of PMA-induced inhibition, with the sole exception of pendrin. These results thus support the proposal of Hassan et al [45] , that oocyte treatment with PMA inhibits mSlc26a6 through activation of PKCδ, despite the shortcomings of rottlerin as a diagnostic inhibitor. Our results also extend the hypothesis of Hassan et al. to human SLC26A6, -A3, and -A2.
To evalute the possibility that the lack of PKCδ regulation of pendrin might reflect a lack of direct phosphoryation, we searched for Ser and Thr residues conserved in the PKCδ-sensitive transporters but absent from pendrin. We found one such Ser residue in SLC26A2, but its mutation in tandem with mutation of a nearby Ser to the corresponding hydrophobic residues present in the PKCδ-insensitive pendrin failed to reduce the inhibitory effect of PKCδ on SLC26A2. This result suggests either PKCδ acts through phosphorylation of other target residues, or that PKCδ-mediated inhibition of SLC26 transporters is indirect. Interestingly, in PC C13 thyrocytes in which endogenous pendrin expression was previously induced by TSH and insulin, PKCε activation appears to promote translocation of pendrin from internal stores to the cell surface [73] . PKCδ and PKCε have also been reported to exert opposing actions on cardiac myocyte hypertrophy [74] . Additional components of the SLC26 PKCδ signaling cascade that do not affect pendrin have not yet been reported.
